EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 27 / No 4 (Avril 2011) Med Sci (Paris), 27 4 (2011) 443-446 References
Free Access
Issue
Med Sci (Paris)
Volume 27, Number 4, Avril 2011
Page(s) 443 - 446
Section Dernière heure
DOI https://doi.org/10.1051/medsci/2011274023
Published online 28 April 2011
  1. MarteynA, MauryY, GauthierMM, et al. Mutant human embryonic stem cells reveal neurite and synapse formation defects in Type 1 myotonic dystrophy. Cell Stem Cell 2011 ; online. [Google Scholar]
  2. EigesR, UrbachA, MalcovM, et al. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007 ; 5 : 568-577. [CrossRef] [Google Scholar]
  3. TakahashiK, TanabeK, OhnukiM, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. cell 2007 ; 5 : 861-872. [Google Scholar]
  4. GoreA, LiZ, FungHL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011 ; 471 : 63-67. [CrossRef] [PubMed] [Google Scholar]
  5. HusseinSM, BatadaNN, VuoristoS, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011 ; 471 : 58-62. [CrossRef] [PubMed] [Google Scholar]
  6. ListerR, PelizzolaM, KidaYS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011 ; 471 : 68-73. [CrossRef] [PubMed] [Google Scholar]
  7. UrbachA, Bar-NurO, DaleyGQ, BenvenistyN.. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2007 ; 5 : 407-411. [Google Scholar]
  8. RanumLP, CooperTA.. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 2006 ; 29 : 259-277. [CrossRef] [PubMed] [Google Scholar]
  9. JiangH, MankodiA, SwansonMS, et al. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 2004 ; 24 : 3079-3088. [CrossRef] [Google Scholar]
  10. StranockSD, DavisJN.. Ultrastructure of the muscle spindle in dystrophia myotonica. II. The sensory and motor nerve terminals. Neuropathol Appl Neurobiol 1978 ; 5 : 407-418. [CrossRef] [Google Scholar]
  11. PanaitePA, GanteletE, KraftsikR, et al. Myotonic dystrophy transgenic mice exhibit pathologic abnormalities in diaphragm neuromuscular junctions and phrenic nerves. J Neuropathol Exp Neurol 2008 ; 8 : 763-772. [CrossRef] [Google Scholar]
  12. NagaoM, KatoS, HayashiH, MisawaH.. Hyperproliferation of synapses on spinal motor neurons of Duchenne muscular dystrophy and myotonic dystrophy patients. Acta Neuropathol 2003 ; 6 : 557-560. [CrossRef] [Google Scholar]
  13. ParkIH, AroraN, HuoH, et al. Disease-specific induced pluripotent stem cells. Cell 2008 ; 134 : 877-886. [CrossRef] [PubMed] [Google Scholar]
  14. KazukiY, HiratsukaM, TakiguchiM, et al. Complete genetic correction of ips cells from Duchenne muscular dystrophy. Mol Ther 2009 ; 2 : 386-393. [Google Scholar]
  15. SoldnerF, HockemeyerD, BeardC, et al. disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009 ; 5 : 964-977. [CrossRef] [Google Scholar]
  16. HargusG, CooperO, DeleidiM, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 2010 ; 107 : 15921-15926. [CrossRef] [Google Scholar]
  17. MaehrR, ChenS, SnitowM, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 2009 ; 37 : 15768-15773. [CrossRef] [Google Scholar]
  18. BaekKH, ZaslavskyA, LynchRC, et al. Down’s syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 2009 ; 7250 : 1126-1130. [CrossRef] [Google Scholar]
  19. EbertAD, YuJ, RoseFFJr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009 ; 7227 : 277-280. [CrossRef] [PubMed] [Google Scholar]
  20. LeeG, PapapetrouEP, KimH, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009 ; 7262 : 402-406. [CrossRef] [Google Scholar]
  21. DimosJT, RodolfaKT, NiakanKK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008 ; 5893 : 1218-1221. [CrossRef] [PubMed] [Google Scholar]
  22. HottaA, CheungAY, FarraN, et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009 ; 5 : 370-376. [CrossRef] [Google Scholar]
  23. MarchettoMC, CarromeuC, AcabA, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010 ; 4 : 527-539. [CrossRef] [PubMed] [Google Scholar]
  24. CheungAY, HorvathLM, GrafodatskayaD, Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet 2011, 17 mars (online). [Google Scholar]
  25. YeL, ChangJC, LinC, et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 2009 ; 24 : 9826-9830. [CrossRef] [Google Scholar]
  26. WangY, JiangY, LiuS, et al. Generation of induced pluripotent stem cells from human beta-thalassemia fibroblast cells. Cell Res 2009 ; 9 : 1120-1123. [CrossRef] [Google Scholar]
  27. ZhangJ, LianQ, ZhuG, et al. A human iPSC model of Hutchinson-Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2010 ; 1 : 31-45. [Google Scholar]
  28. LiuGH, BarkhoBZ, RuizS, et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011, 23 février(online). [Google Scholar]
  29. MorettiA, BellinM, WellingA, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010 ; 15 : 1397-1409. [CrossRef] [Google Scholar]
  30. ItzhakiI, MaizelsL, HuberI, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011 ; 7337 : 225-229. [CrossRef] [Google Scholar]
  31. MatsaE, RajamohanD, DickE, et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur Heart J 2011 ; 2 mars (online). [Google Scholar]
  32. YazawaM, HsuehB, JiaX, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011 ; 7337 : 230-234. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.